Back
GLINT: GlucoCEST in neoplastic tumors at 3 T –preliminary application in glioma patients using optimized preparation, imaging, and post-processing
{Dynamic glucoCEST at clinical field strengths is very challenging due to the low effect size. Here, we present a saturation, imaging and post-processing protocol for minimizing possible artifacts to detect dynamic CEST effects reliably, and demonstrate the application in two glioblastoma patients at 3 T.}
@misc{item_3054605, title = {{GLINT: GlucoCEST in neoplastic tumors at 3 T \textendash preliminary application in glioma patients using optimized preparation, imaging, and post-processing}}, booktitle = {{ISMRM 27th Annual Meeting \& Exhibition}}, abstract = {{Dynamic glucoCEST at clinical field strengths is very challenging due to the low effect size. Here, we present a saturation, imaging and post-processing protocol for minimizing possible artifacts to detect dynamic CEST effects reliably, and demonstrate the application in two glioblastoma patients at 3 T.}}, year = {2019}, slug = {item_3054605}, author = {Herz, K and Lindig, T and Deshmane, A and Bender, B and Golay, X and Ernemann, U and Scheffler, K and Zaiss, M} }